0001724444-22-000004.txt : 20221208 0001724444-22-000004.hdr.sgml : 20221208 20221208103149 ACCESSION NUMBER: 0001724444-22-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221208 DATE AS OF CHANGE: 20221208 EFFECTIVENESS DATE: 20221208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Convelo Therapeutics, Inc. CENTRAL INDEX KEY: 0001724444 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466899 FILM NUMBER: 221451647 BUSINESS ADDRESS: STREET 1: 11000 CEDAR AVENUE STREET 2: SUITE 285B CITY: CLEVELAND STATE: OH ZIP: 44106 BUSINESS PHONE: 2166583969 MAIL ADDRESS: STREET 1: 11000 CEDAR AVENUE STREET 2: SUITE 285B CITY: CLEVELAND STATE: OH ZIP: 44106 D 1 primary_doc.xml X0708 D LIVE 0001724444 Convelo Therapeutics, Inc. 11000 CEDAR AVENUE SUITE 285B CLEVELAND OH OHIO 44106 2166583969 DELAWARE None None Corporation true Paul Tesar c/o Convelo Therapeutics, Inc. 11000 Cedar Avenue, Suite 285B Cleveland OH OHIO 44106 Director Drew Adams c/o Convelo Therapeutics, Inc. 11000 Cedar Avenue, Suite 285B Cleveland OH OHIO 44106 Director Derrick Rossi c/o Convelo Therapeutics, Inc. 11000 Cedar Avenue, Suite 285B Cleveland OH OHIO 44106 Director Bill Sanford c/o Convelo Therapeutics, Inc. 11000 Cedar Avenue, Suite 285B Cleveland OH OHIO 44106 Director Ronald Richard c/o Convelo Therapeutics, Inc. 11000 Cedar Avenue, Suite 285B Cleveland OH OHIO 44106 Director Other Health Care Decline to Disclose 06b false 2022-12-02 false true false 50000 12025000 10823987 1201013 false 1 0 0 400000 true false Convelo Therapeutics, Inc. /Derrick Rossi/ Derrick Rossi Chief Executive Officer 2022-12-08